$HAE
HAEMONETICS CORP Stock $hae

$hae Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000031314324000054 Filed on August 08, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$345.5M	$336.2M
YoY Change	10.98%	10.43%
Cost Of Revenue	$158.1M	$161.2M
YoY Change	9.72%	15.04%
Gross Profit	$187.4M	$174.9M
YoY Change	12.06%	6.5%
Gross Profit Margin	54.25%	52.03%
Selling, General & Admin	$106.9M	$108.2M
YoY Change	14.4%	13.74%
% of Gross Profit	57.06%	61.88%
Research & Development	$16.53M	$14.45M
YoY Change	30.69%	3.47%
% of Gross Profit	8.82%	8.26%
Depreciation & Amortization	$15.00M	$14.60M
YoY Change	12.78%	-38.79%
% of Gross Profit	8.0%	8.35%
Operating Expenses	$135.7M	$135.2M
YoY Change	19.48%	15.42%
Operating Profit	$51.70M	$39.76M
YoY Change	-3.66%	-15.66%
Interest Expense	-$6.993M	$6.957M
YoY Change	237.99%	-364.63%
% of Operating Profit	-13.53%	17.5%
Other Income/Expense, Net	-$6.993M	$6.957M
YoY Change	237.99%
Pretax Income	$44.70M	$46.71M
YoY Change	-13.35%	43.18%
Income Tax	$10.90M	$8.300M
% Of Pretax Income	24.38%	17.77%
Net Earnings	$33.83M	$38.37M
YoY Change	-17.57%	30.6%
Net Earnings / Revenue	9.79%	11.41%
Basic Earnings Per Share	$0.66	$0.75
Diluted Earnings Per Share	$0.66	$0.74
COMMON SHARES
Basic Shares Outstanding	51.18M shares	50.84M shares
Diluted Shares Outstanding	51.24M shares	51.56M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$299.3M	$344.4M
YoY Change	4.75%	21.08%
Cash & Equivalents	$299.3M	$344.4M
Short-Term Investments
Other Short-Term Assets	$60.98M	$58.88M
YoY Change	23.03%	25.98%
Inventory	$382.1M	$373.8M
Prepaid Expenses
Receivables	$213.5M	$201.5M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$955.9M	$978.6M
YoY Change	19.25%	27.13%
LONG-TERM ASSETS
Property, Plant & Equipment	$300.5M	$302.5M
YoY Change	-1.31%	-2.7%
Goodwill	$616.2M	$613.3M
YoY Change	32.25%	31.55%
Intangibles	$487.8M	$494.9M
YoY Change	81.93%	79.47%
Long-Term Investments
YoY Change
Other Assets	$155.8M	$142.3M
YoY Change	32.84%	32.99%
Total Long-Term Assets	$1.569B	$1.562B
YoY Change	35.21%	34.1%
TOTAL ASSETS
Total Short-Term Assets	$955.9M	$978.6M
Total Long-Term Assets	$1.569B	$1.562B
Total Assets	$2.525B	$2.541B
YoY Change	28.69%	31.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$69.24M	$76.93M
YoY Change	-11.38%	20.34%
Accrued Expenses	$49.30M	$40.77M
YoY Change	49.53%	-36.77%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$5.434M	$5.109M
YoY Change	-59.96%	-56.64%
Total Short-Term Liabilities	$273.9M	$260.1M
YoY Change	15.62%	3.28%
LONG-TERM LIABILITIES
Long-Term Debt	$1.220B	$1.218B
YoY Change	62.3%	61.58%
Other Long-Term Liabilities	$90.01M	$92.26M
YoY Change	25.05%	23.49%
Total Long-Term Liabilities	$1.310B	$1.311B
YoY Change	59.05%	58.15%
TOTAL LIABILITIES
Total Short-Term Liabilities	$273.9M	$260.1M
Total Long-Term Liabilities	$1.310B	$1.311B
Total Liabilities	$1.583B	$1.571B
YoY Change	49.34%	45.36%
SHAREHOLDERS EQUITY
Retained Earnings	$368.5M	$386.6M
YoY Change	29.76%	52.72%
Common Stock	$544.9M	$561.4M
YoY Change	-10.69%	-5.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$878.9M	$905.4M
YoY Change
Total Liabilities & Shareholders Equity	$2.525B	$2.541B
YoY Change	28.69%	31.33%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	$33.83M	$38.37M
YoY Change	-17.57%	30.6%
Depreciation, Depletion And Amortization	$15.00M	$14.60M
YoY Change	12.78%	-38.79%
Cash From Operating Activities	$48.82M	-$27.42M
YoY Change	155.81%	-134.44%
INVESTING ACTIVITIES
Capital Expenditures	$11.98M	$5.656M
YoY Change	23.94%	-52.55%
Acquisitions		$149.2M
YoY Change
Other Investing Activities	-$11.39M	-$129.3M
YoY Change	103.48%	2024.69%
Cash From Investing Activities	-$23.37M	-$139.2M
YoY Change	53.12%	673.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$1.563M
YoY Change
Cash From Financing Activities	-74.80M	$333.7M
YoY Change	12409.03%	-20916.72%
NET CHANGE
Cash From Operating Activities	48.82M	-$27.42M
Cash From Investing Activities	-23.37M	-$139.2M
Cash From Financing Activities	-74.80M	$333.7M
Net Change In Cash	-49.35M	$165.6M
YoY Change	-4038.39%	176.04%
FREE CASH FLOW
Cash From Operating Activities	$48.82M	-$27.42M
Capital Expenditures	$11.98M	$5.656M
Free Cash Flow	$36.85M	-$33.08M
YoY Change	291.03%	-148.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	161248000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	144067000	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	174924000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	167265000	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14449000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12648000	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	108248000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	93485000	usd
CY2024Q2	hae	Amortization Of Acquired Intangible Assets AmortizationOfAcquiredIntangibleAssets	12471000	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	135168000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	113606000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	39756000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	53659000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6957000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	46713000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8340000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	38373000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.75
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.74
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50943000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51564000	shares
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	31338000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	344429000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5719000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	201485000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	373787000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	58877000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	978578000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	302480000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	469659000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	494935000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	613347000	usd
CY2024Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	9369000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	142268000	usd
CY2024Q2	us-gaap	Assets Assets	2540977000	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	5109000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	76929000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	40768000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	137270000	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1218477000	usd
CY2024Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	64793000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	92263000	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	51152886	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50787859	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	512000	usd
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	560881000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	386642000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-42667000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	905368000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2540977000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	817997000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	627000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	5773000	usd
CY2023Q3	us-gaap	Restructuring Charges RestructuringCharges	-11000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6989000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	41042000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	863000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	864616000	usd
CY2024Q2	us-gaap	Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpense
CY2024Q2	us-gaap	Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpense
CY2024Q2	us-gaap	Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpense
CY2024Q2	us-gaap	Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpense
CY2023Q3	hae	Amortization Of Acquired Intangible Assets AmortizationOfAcquiredIntangibleAssets	7473000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2069000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	51590000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10548000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	41042000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.81
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.80
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50542000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51340000	shares
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	41905000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	178800000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5695000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	206562000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	317202000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	66339000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	768903000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	311362000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	455213000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	406117000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	565082000	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	7739000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	136388000	usd
CY2024Q1	us-gaap	Assets Assets	2195591000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	10229000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	73358000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	80708000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	136088000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	260076000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	300383000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	797564000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	62644000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	75041000	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	51152886	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50787859	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	508000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	634627000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	360456000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-35632000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	959959000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2195591000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	959959000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	3441000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	961000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2024Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	9759000	usd
CY2024Q2	hae	Adjustments To Additional Paid In Capital Convertible Debt Capped Call Purchases AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases	88200000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7628000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	38373000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-7035000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	905368000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2871000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	38373000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	41042000	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	29136000	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	23032000	usd
CY2024Q2	hae	Amortization Of Fair Value Inventory Step Up AmortizationOfFairValueInventoryStepUp	5239000	usd
CY2023Q3	hae	Amortization Of Fair Value Inventory Step Up AmortizationOfFairValueInventoryStepUp	0	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	7628000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	6989000	usd
CY2024Q2	us-gaap	Gain Loss On Repurchase Of Debt Instrument GainLossOnRepurchaseOfDebtInstrument	12600000	usd
CY2023Q3	us-gaap	Gain Loss On Repurchase Of Debt Instrument GainLossOnRepurchaseOfDebtInstrument	0	usd
CY2024Q2	hae	Benefit Provision For Losses On Inventory BenefitProvisionForLossesOnInventory	-3602000	usd
CY2023Q3	hae	Benefit Provision For Losses On Inventory BenefitProvisionForLossesOnInventory	1785000	usd
CY2024Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	14291000	usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	214000	usd
CY2024Q2	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-1927000	usd
CY2023Q3	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	1726000	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7970000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1010000	usd
CY2024Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	39830000	usd
CY2023Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	29396000	usd
CY2024Q2	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-3223000	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-1595000	usd
CY2024Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	9839000	usd
CY2023Q3	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	9986000	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-44105000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-14927000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-27421000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	19086000	usd
CY2024Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5656000	usd
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7681000	usd
CY2024Q2	hae	Transfers From Inventory To Fixed Assets TransfersFromInventoryToFixedAssets	-4211000	usd
CY2023Q3	hae	Transfers From Inventory To Fixed Assets TransfersFromInventoryToFixedAssets	-1982000	usd
CY2024Q2	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	149151000	usd
CY2023Q3	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2024Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	20362000	usd
CY2023Q3	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	402000	usd
CY2024Q2	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	541000	usd
CY2023Q3	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	6000000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-139197000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15261000	usd
CY2024Q2	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	700000000	usd
CY2023Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2024Q2	hae	Decrease For Redemption Of Convertible Senior Notes DecreaseForRedemptionOfConvertibleSeniorNotes	185500000	usd
CY2023Q3	hae	Decrease For Redemption Of Convertible Senior Notes DecreaseForRedemptionOfConvertibleSeniorNotes	0	usd
CY2024Q2	hae	Purchase Of Capped Call Related To Convertible Notes PurchaseOfCappedCallRelatedToConvertibleNotes	88200000	usd
CY2023Q3	hae	Purchase Of Capped Call Related To Convertible Notes PurchaseOfCappedCallRelatedToConvertibleNotes	0	usd
CY2024Q2	hae	Proceeds From Issuance Of Long Term Debt Excluding Line Of Credit ProceedsFromIssuanceOfLongTermDebtExcludingLineOfCredit	250000000	usd
CY2023Q3	hae	Proceeds From Issuance Of Long Term Debt Excluding Line Of Credit ProceedsFromIssuanceOfLongTermDebtExcludingLineOfCredit	0	usd
CY2024Q2	hae	Decrease For Redemption Of Long Term Debt DecreaseForRedemptionOfLongTermDebt	262500000	usd
CY2023Q3	hae	Decrease For Redemption Of Long Term Debt DecreaseForRedemptionOfLongTermDebt	0	usd
CY2024Q2	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	50000000	usd
CY2023Q3	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	usd
CY2024Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1563000	usd
CY2023Q3	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1750000	usd
CY2024Q2	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	23135000	usd
CY2023Q3	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2024Q2	us-gaap	Employee Stock Ownership Plan Esop Cash Contributions To Esop EmployeeStockOwnershipPlanESOPCashContributionsToESOP	3441000	usd
CY2023Q3	us-gaap	Employee Stock Ownership Plan Esop Cash Contributions To Esop EmployeeStockOwnershipPlanESOPCashContributionsToESOP	2871000	usd
CY2024Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	961000	usd
CY2023Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	627000	usd
CY2024Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	9750000	usd
CY2023Q3	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1483000	usd
CY2024Q2	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-62000	usd
CY2023Q3	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-863000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	333692000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-598000	usd
CY2024Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1445000	usd
CY2023Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1974000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	165629000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1253000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	178800000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	284466000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	344429000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	285719000	usd
CY2024Q2	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	7600000	usd
CY2024Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
CY2024Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	28900000	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.77
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	33600000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	31200000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	13300000	usd
CY2024Q1	us-gaap	Restructuring Reserve RestructuringReserve	11794000	usd
CY2024Q2	us-gaap	Restructuring Charges RestructuringCharges	4622000	usd
CY2024Q2	us-gaap	Payments For Restructuring PaymentsForRestructuring	3158000	usd
CY2024Q2	us-gaap	Restructuring Reserve RestructuringReserve	13258000	usd
CY2024Q2	us-gaap	Restructuring Charges RestructuringCharges	4622000	usd
CY2023Q3	us-gaap	Restructuring Charges RestructuringCharges	-11000	usd
CY2024Q2	us-gaap	Restructuring Reserve RestructuringReserve	13300000	usd
CY2024Q2	us-gaap	Restructuring Charges RestructuringCharges	4622000	usd
CY2024Q2	hae	Restructuring Related Costs RestructuringRelatedCosts	2518000	usd
CY2023Q3	hae	Restructuring Related Costs RestructuringRelatedCosts	2204000	usd
CY2024Q2	hae	Restructuringand Restructuring Related Costs RestructuringandRestructuringRelatedCosts	7140000	usd
CY2023Q3	hae	Restructuringand Restructuring Related Costs RestructuringandRestructuringRelatedCosts	2193000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8300000	usd
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.179
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10500000	usd
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.204
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	38373000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	41042000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50943000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50542000	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.75
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.81
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	38373000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	41042000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50943000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50542000	shares
CY2024Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	621000	shares
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	798000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51564000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51340000	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.74
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.80
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	700000	shares
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	700000	shares
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	600000	shares
CY2022Q3	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	300000000	usd
CY2024Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	225000000	usd
CY2024Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	126814000	usd
CY2024Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	134150000	usd
CY2024Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	39571000	usd
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	15488000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	207402000	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	167564000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	373787000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	317202000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	949044000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	959177000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	646564000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	647815000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	302480000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	311362000	usd
CY2024Q2	us-gaap	Depreciation Depreciation	14600000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	13300000	usd
CY2024Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	19900000	usd
CY2024Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	14100000	usd
CY2024Q2	hae	Operating Lease Revenue As A Percentage Of Total Net Sales OperatingLeaseRevenueAsAPercentageOfTotalNetSales	0.03
CY2024Q1	us-gaap	Goodwill Goodwill	565082000	usd
CY2024Q2	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-19962000	usd
CY2024Q2	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	69542000	usd
CY2024Q2	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-1315000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	613347000	usd
CY2024Q2	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-20000000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	958432000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	469659000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	488773000	usd
CY2024Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	6162000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	843096000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	455213000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	387883000	usd
CY2024Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	18234000	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14500000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9700000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	39591000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	49070000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	47122000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	45350000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	44156000	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	5109000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	10229000	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1218477000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	797564000	usd
CY2024Q2	hae	Debt Instrument Convertible Capped Call Transaction Initial Strike Price DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice	117.12
CY2024Q2	hae	Debt Instrument Convertible Capped Call Transaction Initial Cap Price DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice	180.18
CY2024Q2	hae	Debt Instrument Convertible Capped Call Transaction Anti Dilution Adjustment Shares DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares	5980000	shares
CY2024Q2	hae	Purchase Of Capped Call Related To Convertible Notes PurchaseOfCappedCallRelatedToConvertibleNotes	88200000	usd
CY2024Q2	hae	Debt Instrument Percent Of Principal Amount Due In Years13 DebtInstrumentPercentOfPrincipalAmountDueInYears13	0.025
CY2024Q2	hae	Debt Instrument Percent Of Principal Amount Due In Year4 DebtInstrumentPercentOfPrincipalAmountDueInYear4	0.050
CY2024Q2	hae	Debt Instrument Percent Of Principal Amount Due In Year5 DebtInstrumentPercentOfPrincipalAmountDueInYear5	0.075
CY2024Q2	hae	Consolidated Total Leverage Ratio ConsolidatedTotalLeverageRatio	4.0
CY2024Q2	hae	Consolidated Interest Coverage Ratio ConsolidatedInterestCoverageRatio	4.5
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	3235000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	307916000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	6311000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	12564000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	18818000	usd
CY2024Q2	hae	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	900550000	usd
CY2024Q2	hae	Number Of Interest Rate Swaps Remaining NumberOfInterestRateSwapsRemaining	2	segment
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5695000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4932000	usd
CY2024Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-37000	usd
CY2023Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-151000	usd
CY2024Q2	hae	Accounts Receivable Allowance For Credit Loss Recovery Writeoff AccountsReceivableAllowanceForCreditLossRecoveryWriteoff	13000	usd
CY2023Q3	hae	Accounts Receivable Allowance For Credit Loss Recovery Writeoff AccountsReceivableAllowanceForCreditLossRecoveryWriteoff	36000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5719000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5047000	usd
CY2024Q2	hae	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Value At Acquisition Date FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValueAtAcquisitionDate	25000000	usd
CY2024Q1	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	8700000	usd
CY2024Q2	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	8700000	usd
CY2024	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	6800000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-35632000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-6644000	usd
CY2024Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	391000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-7035000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-42667000	usd
CY2024Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2024Q2	hae	Net Revenues By Business Unit Before Foreign Exchange Impact NetRevenuesByBusinessUnitBeforeForeignExchangeImpact	337287000	usd
CY2023Q3	hae	Net Revenues By Business Unit Before Foreign Exchange Impact NetRevenuesByBusinessUnitBeforeForeignExchangeImpact	311088000	usd
CY2024Q2	hae	Effectof Exchange Rateon Revenues EffectofExchangeRateonRevenues	-1115000	usd
CY2023Q3	hae	Effectof Exchange Rateon Revenues EffectofExchangeRateonRevenues	244000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	336172000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	311332000	usd
CY2024Q2	hae	Effectof Exchange Rateson Operating Income EffectofExchangeRatesonOperatingIncome	-1349000	usd
CY2023Q3	hae	Effectof Exchange Rateson Operating Income EffectofExchangeRatesonOperatingIncome	2613000	usd
CY2024Q2	hae	Amortization Of Acquired Intangible Assets AmortizationOfAcquiredIntangibleAssets	12471000	usd
CY2023Q3	hae	Amortization Of Acquired Intangible Assets AmortizationOfAcquiredIntangibleAssets	7473000	usd
CY2024Q2	hae	Amortization Of Fair Value Inventory Step Up AmortizationOfFairValueInventoryStepUp	5239000	usd
CY2023Q3	hae	Amortization Of Fair Value Inventory Step Up AmortizationOfFairValueInventoryStepUp	0	usd
CY2024Q2	hae	Operating Expenses Transaction Costs OperatingExpensesTransactionCosts	12323000	usd
CY2023Q3	hae	Operating Expenses Transaction Costs OperatingExpensesTransactionCosts	1115000	usd
CY2024Q2	us-gaap	Restructuring Costs RestructuringCosts	-4622000	usd
CY2023Q3	us-gaap	Restructuring Costs RestructuringCosts	11000	usd
CY2024Q2	hae	Restructuring Related Costs RestructuringRelatedCosts	2518000	usd
CY2023Q3	hae	Restructuring Related Costs RestructuringRelatedCosts	2204000	usd
CY2024Q2	hae	Digital Transformation Costs DigitalTransformationCosts	6345000	usd
CY2023Q3	hae	Digital Transformation Costs DigitalTransformationCosts	3705000	usd
CY2024Q2	hae	Impairment Of Assets And Pcs2 Related Charges Credits ImpairmentOfAssetsAndPCS2RelatedChargesCredits	0	usd
CY2023Q3	hae	Impairment Of Assets And Pcs2 Related Charges Credits ImpairmentOfAssetsAndPCS2RelatedChargesCredits	141000	usd
CY2024Q2	hae	European Medical Device Regulation Costs EuropeanMedicalDeviceRegulationCosts	1126000	usd
CY2023Q3	hae	European Medical Device Regulation Costs EuropeanMedicalDeviceRegulationCosts	1166000	usd
CY2024Q2	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	755000	usd
CY2023Q3	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	1058000	usd
CY2024Q2	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	14134000	usd
CY2023Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	39756000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	53659000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	336172000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	311332000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	336172000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	311332000	usd
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000313143-24-000054-index-headers.html	Edgar Link	pending
0000313143-24-000054-index.html	Edgar Link	pending
0000313143-24-000054.txt	Edgar Link	pending
0000313143-24-000054-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hae-20240629.htm	Edgar Link	pending
hae-20240629.xsd	Edgar Link	pending
haefy25q1junex311.htm	Edgar Link	pending
haefy25q1junex312.htm	Edgar Link	pending
haefy25q1junex321.htm	Edgar Link	pending
haefy25q1junex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
hae-20240629_cal.xml	Edgar Link	unprocessable
hae-20240629_def.xml	Edgar Link	unprocessable
hae-20240629_lab.xml	Edgar Link	unprocessable
hae-20240629_pre.xml	Edgar Link	unprocessable
hae-20240629_htm.xml	Edgar Link	completed
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HAE
HAEMONETICS CORP Stock $hae

2024 Q3 Form 10-Q Financial Statement

#000031314324000054 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HAE HAEMONETICS CORP Stock $hae

2024 Q3 Form 10-Q Financial Statement

#000031314324000054 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HAE
HAEMONETICS CORP Stock $hae